CN102224151A - 新的抗微生物剂 - Google Patents

新的抗微生物剂 Download PDF

Info

Publication number
CN102224151A
CN102224151A CN2009801465662A CN200980146566A CN102224151A CN 102224151 A CN102224151 A CN 102224151A CN 2009801465662 A CN2009801465662 A CN 2009801465662A CN 200980146566 A CN200980146566 A CN 200980146566A CN 102224151 A CN102224151 A CN 102224151A
Authority
CN
China
Prior art keywords
alkyl
heteroaryl
cycloalkyl
aryl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801465662A
Other languages
English (en)
Chinese (zh)
Inventor
拉杰什·贾殷
桑贾伊·特雷汉
加戈塔兰·达斯
桑迪普·坎沃尔
西塔拉姆·库马尔·马格蒂
苏迪尔·库马尔·夏尔玛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panacea Biotec Ltd
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of CN102224151A publication Critical patent/CN102224151A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CN2009801465662A 2008-11-20 2009-11-18 新的抗微生物剂 Pending CN102224151A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2623/DEL/2008 2008-11-20
IN2623DE2008 2008-11-20
PCT/IN2009/000658 WO2010058423A2 (en) 2008-11-20 2009-11-18 Novel antimicrobials

Publications (1)

Publication Number Publication Date
CN102224151A true CN102224151A (zh) 2011-10-19

Family

ID=42198604

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801465662A Pending CN102224151A (zh) 2008-11-20 2009-11-18 新的抗微生物剂

Country Status (12)

Country Link
US (1) US8841306B2 (https=)
EP (1) EP2367820B1 (https=)
JP (1) JP5662940B2 (https=)
KR (1) KR20110092309A (https=)
CN (1) CN102224151A (https=)
AR (1) AR074387A1 (https=)
AU (1) AU2009318783A1 (https=)
CA (1) CA2743971A1 (https=)
MX (1) MX2011005365A (https=)
RU (1) RU2522582C2 (https=)
WO (1) WO2010058423A2 (https=)
ZA (1) ZA201103978B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103450173A (zh) * 2013-09-07 2013-12-18 吉首大学 吡咯酮-苯基-噁唑烷酮型化合物及其制法和用途

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2532703T3 (es) 2010-10-13 2015-03-31 Glaxo Group Limited Derivados de 3-amino-pirazol útiles contra la tuberculosis
PT106651A (pt) * 2012-11-20 2014-05-20 Tecnimede Sociedade Tecnico Medicinal S A Quinolil hidrazonas para o tratamento de tuberculose e doenças relacionadas
WO2017156519A1 (en) 2016-03-11 2017-09-14 The Board Of Trustees Of The University Of Illinois Small-molecules active against gram-negative bacteria
US11274106B2 (en) 2017-06-23 2022-03-15 The Board Of Trustees Of The University Of Illinois Topoisomerase inhibitors with antibacterial and anticancer activity
AU2021217225A1 (en) * 2020-02-07 2022-10-06 University Of South Florida Inhibition of beta-arrestin oligomerization in tauopathy

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE146783T1 (de) 1991-11-01 1997-01-15 Upjohn Co Substituierte aryl- und heteroaryl- phenyloxazolidinone
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
WO1995007272A1 (fr) 1993-09-06 1995-03-16 Fujisawa Pharmaceutical Co., Ltd. Compose de cyclodepsipeptide
NZ306310A (en) 1995-05-11 2001-05-25 Upjohn Co Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
RU2175324C2 (ru) 1995-09-01 2001-10-27 Фармация Энд Апджон Компани Фенилоксазолидиноны, имеющие с-с-связь с 4-8-членными гетероциклическими кольцами
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
TR200003595T2 (tr) * 1998-06-05 2001-07-23 Astrazeneca Ab Kimyasal bileşikler
JP2000204084A (ja) * 1998-11-11 2000-07-25 Hokuriku Seiyaku Co Ltd チオカルバミド酸誘導体
WO2000029396A1 (de) 1998-11-17 2000-05-25 Bayer Aktiengesellschaft Neue substituierte phenyloxazolidon-derivate
ES2203473T3 (es) 1999-05-27 2004-04-16 PHARMACIA & UPJOHN COMPANY Oxazolidinonas biciclicas como agentes antibacterianos.
US6608081B2 (en) 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
BR0111280A (pt) 2000-06-05 2003-06-10 Dong A Pharm Co Ltd Novos derivados de oxazolidinona e um processo para a preparação dos mesmos
ES2245698T3 (es) 2000-06-30 2006-01-16 PHARMACIA & UPJOHN COMPANY LLC Composiciones para el tratamiento de infecciones bacterianas que contienen un compuesto de oxazolidinona, sulbactam y ampicilina.
DOP2002000333A (es) 2001-02-14 2002-09-30 Warner Lambert Co Derivados de acido isoftalico como inhibidores de metaloproteinasas de la matriz
ES2268011T3 (es) 2001-04-07 2007-03-16 Astrazeneca Ab Oxazolidinonas que contienen un grupo sulfonimida como antibioticos.
GB0108793D0 (en) 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
AU2002333233A1 (en) 2001-07-09 2003-01-29 Pharmacia Italia Spa Interaction inhibitors of tcf-4 with beta-catenin
EP1409464A4 (en) 2001-07-16 2005-11-02 Ranbaxy Lab Ltd OXAZOLIDINONE DERIVATIVES AS POTENTIAL ANTIMICROBIALS
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US20050209248A1 (en) 2002-05-15 2005-09-22 Biswajit Das Plymorphic forms of phenyl oxazolidinone derivatives
WO2003097640A1 (en) 2002-05-22 2003-11-27 Orchid Chemicals & Pharmaceuticals Ltd. Oxazolidinone derivatives as antibacterial agents
WO2004009587A1 (en) 2002-07-22 2004-01-29 Orchid Chemicals & Pharmaceuticals Ltd Oxazolidinone derivatives as antibacterial agents
MXPA05001199A (es) 2002-07-29 2005-05-16 Ranbaxy Lab Ltd Derivados de oxazolidinona como antimicrobianos.
EP1578734A1 (en) 2002-08-22 2005-09-28 Orchid Chemicals and Pharmaceuticals Ltd Novel antibacterial agents
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
JP2006509035A (ja) * 2002-11-21 2006-03-16 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌剤としてのｎ−（４−（ピペラジン−１−イル）−フェニル−２−オキサゾリジノン−５−カルボキサミド誘導体および関連化合物
GB0229526D0 (en) 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
GB0229518D0 (en) 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
CN1237056C (zh) * 2002-12-25 2006-01-18 中国科学院上海药物研究所 噁唑烷酮类化合物、其制备方法和用途
US20080214565A1 (en) * 2003-04-07 2008-09-04 Anita Mehta Oxazolidinone Derivatives as Antimicrobials
BRPI0409217A (pt) 2003-04-09 2006-03-28 Pharmacia & Upjohn Co Llc derivados e análogos antimicrobianos da [3.1.0]bicicloexilfeniloxazolidinona
WO2004113329A1 (en) 2003-06-20 2004-12-29 Orchid Chemicals And Pharmaceuticals Ltd. Oxazole derivatives as antibacterial agents
WO2005003087A2 (en) 2003-07-01 2005-01-13 Orchid Chemicals And Pharmaceuticals Ltd. Oxazole derivatives as antibacterial agents
CA2529294A1 (en) 2003-07-02 2005-01-20 Merck & Co., Inc. Oxazolidinone antibiotics and derivatives thereof
WO2005005399A1 (en) 2003-07-02 2005-01-20 Merck & Co., Inc. Oxazolidinone antibiotics and derivatives thereof
WO2005036169A2 (en) * 2003-10-03 2005-04-21 Cumbre Inc. Fluorescent probes for ribosomes and method of use
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
WO2005082897A1 (en) 2004-01-28 2005-09-09 Pharmacia & Upjohn Company Llc Oxazolidinone antibacterial agents
WO2005082900A2 (en) 2004-01-28 2005-09-09 Pharmacia & Upjohn Company Llc Oxazolidinone amidoximes as antibacterial agents
WO2005116024A1 (en) 2004-05-25 2005-12-08 Astrazeneca Ab 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as mao inhibitors for the treatment of bacterial infections
US20080064689A1 (en) 2004-05-25 2008-03-13 Astrazeneca Ab 3-[4-(6-Pyridin-3-Yl)-3-Phenyl] -5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents
WO2006035283A1 (en) 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
WO2006043121A1 (en) 2004-10-20 2006-04-27 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
JP5289043B2 (ja) 2005-04-12 2013-09-11 ヴィコール・ファルマ・アーベー 新規な三環系アンジオテンシンｉｉアゴニスト
EP1745784A1 (en) 2005-06-27 2007-01-24 Ferrer Internacional, S.A. Oxazolidinone derivatives and use thereof as antibiotics
WO2007004037A1 (en) 2005-07-06 2007-01-11 Pharmacia & Upjohn Company Llc Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents
KR20070038236A (ko) 2005-10-05 2007-04-10 일동제약주식회사 신규 옥사졸리디논 포름 아미드 유도체 및 그 제조방법
JP2009523764A (ja) * 2006-01-19 2009-06-25 ラボラトリオス・サルバト・ソシエダッド・アノニマ 抗菌活性を有するジカルボニル化合物
US20090318431A1 (en) 2006-02-14 2009-12-24 Pfizer Inc. Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents
CN100406455C (zh) 2006-02-20 2008-07-30 中国科学院上海药物研究所 含三氮唑基的噁唑烷酮类化合物及其制备方法和用途
KR20080110877A (ko) 2006-03-31 2008-12-19 재단법인 이쯔우 연구소 헤테로환을 갖는 신규 화합물
WO2009001192A2 (en) * 2007-06-22 2008-12-31 Orchid Research Laboratories Limited Novel compounds and their use
CN101434584A (zh) * 2007-11-15 2009-05-20 中山大学 具有抗菌活性的手性噁唑烷酮类化合物

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103450173A (zh) * 2013-09-07 2013-12-18 吉首大学 吡咯酮-苯基-噁唑烷酮型化合物及其制法和用途
CN103450173B (zh) * 2013-09-07 2015-06-03 吉首大学 吡咯酮-苯基-噁唑烷酮型化合物及其制法和用途

Also Published As

Publication number Publication date
EP2367820A4 (en) 2012-06-20
WO2010058423A2 (en) 2010-05-27
EP2367820A2 (en) 2011-09-28
CA2743971A1 (en) 2010-05-27
WO2010058423A9 (en) 2011-04-28
JP5662940B2 (ja) 2015-02-04
RU2011124795A (ru) 2012-12-27
US8841306B2 (en) 2014-09-23
US20110245258A1 (en) 2011-10-06
AR074387A1 (es) 2011-01-12
ZA201103978B (en) 2012-09-26
MX2011005365A (es) 2011-06-24
RU2522582C2 (ru) 2014-07-20
KR20110092309A (ko) 2011-08-17
AU2009318783A1 (en) 2011-06-23
EP2367820B1 (en) 2016-09-21
JP2012509313A (ja) 2012-04-19
WO2010058423A3 (en) 2010-12-09

Similar Documents

Publication Publication Date Title
CN1046276C (zh) 取代羟基乙酰基哌嗪苯基唑烷酮酯及其用途
EP2305657B1 (en) Oxazolidinone derivatives
TWI773687B (zh) β內醯胺酶抑制劑化合物
EP0882041B1 (en) Piperazinonephenyloxazolidinone derivatives and their use as antibacterial agents
JP2006519247A (ja) 抗生物質として有用なヒドロキシメチル置換ジヒドロイソオキサゾール誘導体
BRPI0708524A2 (pt) compostos de n-formil hidroxilamina
KR102769880B1 (ko) β-락타마제 억제제 및 그 용도
HRP20030522A2 (en) Heterocyclic compounds having antibacterial activity, process for their preparatoin and pharmaceutical compositions containing them
JP2016536338A (ja) 抗微生物化合物ならびにそれの製造方法および使用方法
WO2008143649A2 (en) Novel oxazolidinone compounds as antiinfective agents
CN102224151A (zh) 新的抗微生物剂
WO2018177302A1 (zh) 含氮杂环取代的苯并噁嗪噁唑烷酮类化合物及其制备方法和用途
CN113214288A (zh) 苯并[1,3]噁嗪-噁唑烷酮类化合物及其制备方法和用途
JP6671541B2 (ja) 抗菌剤として有用な複素環式化合物及びその生成方法
JP2006508934A (ja) 抗菌性の［３．１．０］二環式オキサゾリジノン誘導体
KR20100138978A (ko) 신규한 3-카르복시-옥사디아지노-퀴놀론의 7-치환 유도체, 그것의 제조방법 및 항박테리아제로서의 그것의 용도
JP2009523764A (ja) 抗菌活性を有するジカルボニル化合物
JP2020527149A (ja) 新規アルビシジン誘導体、それらの使用および合成
US20040102494A1 (en) Novel heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them
JP2902836B2 (ja) 光学活性ピリドベンゾオキサジン誘導体
KR100529815B1 (ko) 피리도벤즈옥사진 유도체 및 이를 포함하는 항균제
CN100390169C (zh) 用作抗生素药物的羟甲基取代的二氢异唑衍生物
JP2004203809A (ja) 新規ビフェニル誘導体
JPWO2005073238A1 (ja) ピリドベンズオキサジン誘導体
CN114423766A (zh) 用于治疗细菌感染的青霉烷衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20111019